Fortress Biotech Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | -129.1% | – | |
| – | -37.9% | -30.3% | +0.0% | +179.0% | -137.3% | – | -31.0% | +0.1% | +0.0% | +46.8% | -37.4% | – | |
| – | -15.4% | +31.1% | +2.9% | +31.5% | +146.3% | -61.2% | +167.0% | -81.0% | -23.1% | -28.6% | +63.9% | – | |
| – | – | – | -156.3% | – | – | – | – | – | – | – | -196.1% | – | |
| – | -93.7% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -101.3% | – | – | – | – | – | +422.4% | -52.8% | +152.6% | – | – | – | |
| – | -0.2% | -0.2% | +0.0% | -91.9% | -5.7% | +0.0% | +0.0% | +0.0% | +0.0% | -100.0% | – | – | |
| – | -544.4% | -100.0% | – | -100.0% | – | – | -23.3% | -100.0% | – | – | -100.0% | – | |
| – | – | – | – | – | – | -100.0% | – | -85.7% | -100.0% | – | -100.0% | – | |
| – | – | -36.1% | -48.8% | -81.0% | +851.9% | +102.1% | -91.3% | +233.4% | -62.1% | -580.0% | – | – | |
| – | – | -60.0% | -406.4% | – | – | – | -150.2% | – | -157.8% | – | -133.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -129.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.